Alcyone Lifesciences
Pioneers next-generation intra-CSF CNS precision gene-based therapeutics for complex neurological conditions.
Launch date
Employees
Market cap
-
Enterprise valuation
€84—125m (Dealroom.co estimates Jun 2021.)
Ayer Massachusetts (HQ)
Authorizing premium user...